BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36352324)

  • 1. Inducible over-expression of cardiac Nos1ap causes short QT syndrome in transgenic mice.
    Jänsch M; Lubomirov LT; Trum M; Williams T; Schmitt J; Schuh K; Qadri F; Maier LS; Bader M; Ritter O
    FEBS Open Bio; 2023 Jan; 13(1):118-132. PubMed ID: 36352324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.
    Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH
    Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress Induced Ventricular Arrhythmia and Impairment of Cardiac Function in Nos1ap Deleted Mice.
    Sugiyama K; Sasano T; Kurokawa J; Takahashi K; Okamura T; Kato N; Isobe M; Furukawa T
    Int Heart J; 2016 May; 57(3):341-9. PubMed ID: 27170476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.
    Lehtinen AB; Newton-Cheh C; Ziegler JT; Langefeld CD; Freedman BI; Daniel KR; Herrington DM; Bowden DW
    Diabetes; 2008 Apr; 57(4):1108-14. PubMed ID: 18235038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis for Genetic Modifiers of Disease Severity in Patients With Long-QT Syndrome Type 2.
    Kolder ICRM; Tanck MWT; Postema PG; Barc J; Sinner MF; Zumhagen S; Husemann A; Stallmeyer B; Koopmann TT; Hofman N; Pfeufer A; Lichtner P; Meitinger T; Beckmann BM; Myerburg RJ; Bishopric NH; Roden DM; Kääb S; Wilde AAM; Schott JJ; Schulze-Bahr E; Bezzina CR
    Circ Cardiovasc Genet; 2015 Jun; 8(3):447-456. PubMed ID: 25737393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.
    Raitakari OT; Blom-Nyholm J; Koskinen TA; Kähönen M; Viikari JS; Lehtimäki T
    Ann Med; 2009; 41(2):144-51. PubMed ID: 18785031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.
    Kapoor A; Sekar RB; Hansen NF; Fox-Talbot K; Morley M; Pihur V; Chatterjee S; Brandimarto J; Moravec CS; Pulit SL; ; Pfeufer A; Mullikin J; Ross M; Green ED; Bentley D; Newton-Cheh C; Boerwinkle E; Tomaselli GF; Cappola TP; Arking DE; Halushka MK; Chakravarti A
    Am J Hum Genet; 2014 Jun; 94(6):854-69. PubMed ID: 24857694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of rs10918594 polymorphisms of nitric oxide synthase 1 adaptor protein (NOS1AP) with QTc interval prolongation during kidney transplantation.
    Kaczmarczyk M; Biernawska J; Zukowski M; Kotfis K; Zegan-Barańska M; Bińczak-Kuleta A; Ciechanowicz A; Brykczyński M; Bohatyrewicz R
    Transplant Proc; 2011 Oct; 43(8):2964-6. PubMed ID: 21996201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome.
    Tomás M; Napolitano C; De Giuli L; Bloise R; Subirana I; Malovini A; Bellazzi R; Arking DE; Marban E; Chakravarti A; Spooner PM; Priori SG
    J Am Coll Cardiol; 2010 Jun; 55(24):2745-52. PubMed ID: 20538168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A NOS1AP gene variant is associated with a paradoxical increase of the QT-interval shortening effect of digoxin.
    Soroush N; Aarnoudse AJ; Kavousi M; Kors JA; Ikram MA; Newton-Cheh C; Ahmadizar F; Stricker BH
    Pharmacogenomics J; 2022 Feb; 22(1):55-61. PubMed ID: 34616002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.
    Eijgelsheim M; Aarnoudse AL; Rivadeneira F; Kors JA; Witteman JC; Hofman A; van Duijn CM; Uitterlinden AG; Stricker BH
    Hum Mol Genet; 2009 Jan; 18(2):347-57. PubMed ID: 18927126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes.
    Lu J; Hu C; Hu W; Zhang R; Wang C; Qin W; Yu W; Xiang K; ; Jia W
    Diabet Med; 2010 Sep; 27(9):1074-9. PubMed ID: 20722683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.
    Kao WH; Arking DE; Post W; Rea TD; Sotoodehnia N; Prineas RJ; Bishe B; Doan BQ; Boerwinkle E; Psaty BM; Tomaselli GF; Coresh J; Siscovick DS; Marbán E; Spooner PM; Burke GL; Chakravarti A
    Circulation; 2009 Feb; 119(7):940-51. PubMed ID: 19204306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac muscle-restricted partial loss of Nos1ap expression has limited but significant impact on electrocardiographic features.
    Smith A; Auer D; Johnson M; Sanchez E; Ross H; Ward C; Chakravarti A; Kapoor A
    G3 (Bethesda); 2023 Nov; 13(11):. PubMed ID: 37708408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
    Ronchi C; Bernardi J; Mura M; Stefanello M; Badone B; Rocchetti M; Crotti L; Brink P; Schwartz PJ; Gnecchi M; Zaza A
    Cardiovasc Res; 2021 Jan; 117(2):472-483. PubMed ID: 32061134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
    Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
    Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOS1AP modulates intracellular Ca(2+) in cardiac myocytes and is up-regulated in dystrophic cardiomyopathy.
    Treuer AV; Gonzalez DR
    Int J Physiol Pathophysiol Pharmacol; 2014; 6(1):37-46. PubMed ID: 24665357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOS1AP is a genetic modifier of the long-QT syndrome.
    Crotti L; Monti MC; Insolia R; Peljto A; Goosen A; Brink PA; Greenberg DA; Schwartz PJ; George AL
    Circulation; 2009 Oct; 120(17):1657-63. PubMed ID: 19822806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Shah SA; Herrington DM; Howard TD; Divers J; Arnett DK; Burke GL; Kao WH; Guo X; Siscovick DS; Chakravarti A; Lima JA; Psaty BM; Tomaselli GF; Rich SS; Bowden DW; Post W
    Ann Noninvasive Electrocardiol; 2013 Jan; 18(1):29-40. PubMed ID: 23347024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Meta-Analysis of the Association Between a Common NOS1AP Genetic Polymorphism, the QTc Interval, and Sudden Death.
    Zang X; Li S; Zhao Y; Chen K; Wang X; Song W; Ma J; Tu X; Xia Y; Zhang S; Gao C
    Int Heart J; 2019 Sep; 60(5):1083-1090. PubMed ID: 31447468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.